Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
At close: Aug 19, 2026
Waverley Pharma Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.07 | 0.04 | 0.24 | 0.05 | 0.13 | 0.16 |
Cash & Short-Term Investments | 0.07 | 0.04 | 0.24 | 0.05 | 0.13 | 0.16 |
Cash Growth | -52.23% | -80.95% | 345.02% | -60.38% | -15.38% | -77.75% |
Accounts Receivable | 0.02 | 0.03 | 0.05 | 0.14 | 0.19 | 0.42 |
Other Receivables | 0 | 0 | 0.16 | 0 | 0 | 0.28 |
Receivables | 0.02 | 0.03 | 0.21 | 0.14 | 0.19 | 0.7 |
Inventory | 0.29 | 0.31 | 0.26 | 0 | 0.06 | 0.33 |
Prepaid Expenses | 0.03 | 0.04 | 0.02 | 0.22 | 0.24 | 0.26 |
Total Current Assets | 0.4 | 0.42 | 0.73 | 0.42 | 0.63 | 1.45 |
Property, Plant & Equipment | 0.22 | 0.22 | 0.26 | - | - | - |
Goodwill | 0.22 | 0.21 | 0.22 | - | - | - |
Other Intangible Assets | 0.32 | 0.33 | 0.4 | - | 1.68 | 1.76 |
Other Long-Term Assets | 0.04 | 0.06 | 0.43 | 0.54 | 0.38 | 0.48 |
Total Assets | 1.19 | 1.24 | 2.05 | 0.95 | 2.69 | 3.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.38 | 0.37 | 0.96 | 0.45 | 0.72 | 1.03 |
Accrued Expenses | - | 0 | 0.05 | - | 0.17 | 0.59 |
Short-Term Debt | 3.32 | 3.22 | 2.81 | 1.6 | 0.66 | 0.22 |
Current Portion of Long-Term Debt | - | - | - | - | 0.04 | 0.04 |
Current Portion of Leases | 0.05 | 0.05 | 0.04 | - | - | - |
Current Income Taxes Payable | 0 | 0 | - | - | - | - |
Other Current Liabilities | 0 | - | - | 0.04 | 0 | 0.02 |
Total Current Liabilities | 3.75 | 3.64 | 3.86 | 2.09 | 1.6 | 1.89 |
Long-Term Leases | 0.17 | 0.18 | 0.22 | - | - | - |
Total Liabilities | 3.92 | 3.82 | 4.08 | 2.09 | 1.6 | 1.89 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7 | 7 | 7 | 7 | 7 | 7 |
Additional Paid-In Capital | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 |
Retained Earnings | -11.01 | -10.84 | -10.34 | -9.4 | -7.17 | -6.51 |
Comprehensive Income & Other | 0.47 | 0.46 | 0.5 | 0.45 | 0.45 | 0.49 |
Shareholders' Equity | -2.73 | -2.57 | -2.03 | -1.14 | 1.09 | 1.79 |
Total Liabilities & Equity | 1.19 | 1.24 | 2.05 | 0.95 | 2.69 | 3.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.54 | 3.44 | 3.07 | 1.6 | 0.7 | 0.26 |
Net Cash (Debt) | -3.47 | -3.4 | -2.83 | -1.55 | -0.57 | -0.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.06 | -0.06 | -0.05 | -0.03 | -0.01 | -0.00 |
Filing Date Shares Outstanding | 54 | 54 | 54 | 54 | 54 | 54 |
Total Common Shares Outstanding | 54 | 54 | 54 | 54 | 54 | 54 |
Working Capital | -3.34 | -3.22 | -3.13 | -1.67 | -0.96 | -0.45 |
Book Value Per Share | -0.05 | -0.05 | -0.04 | -0.02 | 0.02 | 0.03 |
Tangible Book Value | -3.26 | -3.11 | -2.65 | -1.14 | -0.59 | 0.03 |
Tangible Book Value Per Share | -0.06 | -0.06 | -0.05 | -0.02 | -0.01 | 0.00 |
Machinery | - | 0.01 | 0.01 | - | - | - |